0001766205-23-000003.txt : 20230221 0001766205-23-000003.hdr.sgml : 20230221 20230221142018 ACCESSION NUMBER: 0001766205-23-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230221 DATE AS OF CHANGE: 20230221 EFFECTIVENESS DATE: 20230221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tellus Therapeutics, Inc. CENTRAL INDEX KEY: 0001766205 IRS NUMBER: 832390392 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-473928 FILM NUMBER: 23647446 BUSINESS ADDRESS: STREET 1: 8 DAVIS DRIVE STREET 2: SUITE 220 CITY: DURHAM STATE: NC ZIP: 27709 BUSINESS PHONE: 919-491-4995 MAIL ADDRESS: STREET 1: 8 DAVIS DRIVE STREET 2: SUITE 220 CITY: DURHAM STATE: NC ZIP: 27709 D 1 primary_doc.xml X0708 D LIVE 0001766205 Tellus Therapeutics, Inc. 8 DAVIS DRIVE SUITE 220 DURHAM NC NORTH CAROLINA 27709 919-491-4995 DELAWARE None None Corporation true 2022 Jason E. Kralic 8 Davis Drive Suite 220 Durham NC NORTH CAROLINA 27709 Executive Officer Director Eric J. Benner 8 Davis Drive Suite 220 Durham NC NORTH CAROLINA 27709 Executive Officer Director Chris Garabedian 8 Davis Drive Suite 220 Durham NC NORTH CAROLINA 27709 Director Fred Callori 8 Davis Drive Suite 220 Durham NC NORTH CAROLINA 27709 Director Pharmaceuticals Decline to Disclose 06b false 2022-11-17 false true false 0 35000000 15999999 19000001 false 1 0 0 0 None other than payments of salary in the ordinary course of business to certain of the parties named in response to Item 3. false Tellus Therapeutics, Inc. /s/ Jason Kralic Jason Kralic President and Chief Executive Officer 2023-02-21